Oxybutynin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Oxybutynin and local guidelines before prescribing.

Antimuscarinic

Mechanism

Antimuscarinic reducing detrusor contractions.

Uses

Overactive bladder, nocturnal enuresis, hyperhidrosis.

Dosing

Side effects

Dry mouth, constipation, blurred vision, confusion, urinary retention.

Interactions

Other anticholinergics additive; acetylcholinesterase inhibitors antagonistic.

Contraindications and cautions

Glaucoma, urinary retention, myasthenia gravis

Monitoring

Bladder emptying, cognition

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in older and renal impairment

Overdose and reversal

Physostigmine rarely

Special advice

Avoid in older people with cognitive impairment; consider mirabegron as alternative.

More from the textbook: uses, cautions and other points
Where it is discussed in the book